Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company is operating in a highly competitive segment. It marked a setback in FY22 following the fire incident. Now it is on a fast track as indicated by the 11M-FY23 performance. Based on FY23 earnings, the issue appears fully priced. Well-informed investors may consider parking funds for the medium to long-term rewards. Read detail review...
Crop Life Science Limited peer comparison with similar listed entities. (Standalone) (As on March 31, 2022)
| Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) |
|---|---|---|---|---|
| EPS Basic | ||||
| Crop Life Science Limited | 2.35 | 30.02 | 22.13 | 7.97 |
| Aristo Bio-Tech and Lifescience Limited | 2.87 | 29.76 | 25.38 | 9.65 |
| Dharmaj Crop Guard Limited | 11.62 | 34.40 | 17.26 | 33.84 |
| Heranba Industries Limited | 47.25 | 178.56 | 7.83 | 26.46 |
Notes:
Crop Life Science IPO Reviews, analysis and views by popular members. Read Crop Life Science Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP